フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
IRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission...
WARREN, N.J., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty...
BlackRock, Inc. (NYSE: BLK) today announced product enhancements to two iShares ETFs as part of an ongoing process to periodically review its...
LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on...
CAMBRIDGE, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a...
RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a...
Mirati Therapeutics Added To NASDAQ Biotechnology Index PR Newswire SAN DIEGO, Dec. 20, 2018 SAN DIEGO, Dec...
DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc...
BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF...
LA JOLLA, Calif., Dec. 14, 2016 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded...
Blueprint Medicines Added to NASDAQ Biotechnology Index PR Newswire CAMBRIDGE, Mass., Dec. 17, 2015 CAMBRIDGE, Mass., Dec. 17, 2015 /PRNewswire/...
Egalet Added to NASDAQ Biotechnology Index PR Newswire WAYNE, Pa., Dec. 17, 2015 WAYNE, Pa., Dec. 17, 2015 /PRNewswire/ -- Egalet Corporation...
CANTON, Mass., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced...
LONDON, Dec. 22, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (GW, the Company or the Group), a biopharmaceutical...
NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company developing...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約